Additionally, regulatory T cells (Tregs) significantly increased in the liver of diabetes vs. non-diabetes (p < 0.01) [25], while CD4+CD44+CD62L− and CD8+CD44+CD62L− effector memory T cells were increased in diabetes with NASH compared to diabetes alone (both p < 0.01) [31] (Table 1). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.